NEULAND LABORATORIES LTD. - 524558 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Neuland Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here NEULAND LABORATORIES LTD. - 524558 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting results, Scrutinizer report and Proceedings of Annual General Meeting held on 02-Aug-2022 NEULAND LABORATORIES LTD. - 524558 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Voting results, Scrutinizer report and Proceedings of Annual General Meeting held on 02-Aug-2022 NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Call Intimation for Q1 FY23 NEULAND LABORATORIES LTD. - 524558 - Clarification Letter Dated 15/07/2022
Clarification Letter dated 15/07/2022 NEULAND LABORATORIES LTD. - 524558 - Clarification sought from Neuland Laboratories Ltd
The Exchange has sought clarification from Neuland Laboratories Ltd on July 15, 2022, with reference to Movement in Volume.The reply is awaited. NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2022
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2022 ,inter alia, to consider and approve the unaudited financial results of the Company for the Quarter ended June 30, 2022 NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Newspaper Publication NEULAND LABORATORIES LTD. - 524558 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sarada BhamidipatiDesignation :- Company Secretary and Compliance Officer NEULAND LABORATORIES LTD. - 524558 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018